Health Care Flat on Rotation From Rate-Sensitive Sectors -- Health Care Roundup

Health-care companies were flat as traders rotated into sectors less sensitive to moves in interest rates.

Anne Wojcicki is seeking to take her DNA-testing company 23andMe private after three years in public markets that saw its valuation collapse from a high of $6 billion.

Shares of Ocular Therapeutix fell even after the company reported promising early-stage clinical trial data for diabetes-related eye-condition drug candidate Axpaxli.

Write to Rob Curran at [e-mail]

(END) Dow Jones Newswires

04-18-24 1747ET